Crowdonomics
WatchlistPortfolio
All companies
Actipulse Neuroscience logo

Actipulse Neuroscience

Operating

Actipulse Neuroscience, Inc.

Healthcare · Cambridge, DE · Founded 2019

Minority-founded
Visit website

Bringing neuromodulation treatment for depression, from the hospital to the home

Valuation cap ⓘ
$10.0M
As of Nov 2021 · from Reg CF Offering (2021) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$1,522,382
Crowd $202K · Private $1.3M · 4 rounds since 2020
Latest share price
$0.0001
Section 4(a)(2) · Common Stock · Jan 2021 offering price

Financials

FY2019–FY2022 · from SEC filings · hover any figure for its source
$583K
$79K
2019
$248K
$26K
2020
$3K
−$25K
2021
$174K
$9K
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019 reviewed*
FY2020 reviewed*
FY2021
FY2022
Income statement
Revenue
$583,433
$248,406
$2,609
$173,963
Cost of goods sold
$172,299
$6,267
$138
$1,928
Gross margin
70%
97%
95%
99%
Net income
$79,323
$26,070
-$24,691
$9,308
Taxes paid
$34,723
$33,720
$0
$0
Balance sheet
Cash
$22,189
$43,612
$233,595
$828,839
Accounts receivable
$187,973
$182,624
$182,624
$182,624
Total assets
$329,668
$438,383
$685,366
$1,654,564
Short-term debt
$184,420
$94,111
$96,654
$146,013
Long-term debt
$0
$172,654
$172,654
$172,654
Total liabilities
$184,420
$266,765
$269,308
$318,667
Other
Headcount
—
0
0
0

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Valuation caps on SAFE / convertible note rounds
$10.0M
Valuation cap
Reg CF · SAFE · Aug 2021

Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth.

Fundraising history

Section 4(a)(2) · SAFE · Jan 2022Closed
Raised $720K
Section 4(a)(2) · Common Stock · Jan 2021Closed
Raised $500.8K
Reg CF · SAFE · Aug 2021Closedvia Republic
Raised $201.6K / $1.1MInvestors 498Valuation cap $10M

Team

1 person
Adrien Chatillon
Chief Executive Officer

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFiled Form C-TR (terminated reporting)

Filed 2 of 5 annual reports (FY2021–FY2025)

498 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-TRApr 13, 20230001860502-23-000002
    EDGAR
  • Form C-ARApr 13, 20230001860502-23-000001
    EDGAR
  • Form C-ARMay 11, 20220001860502-22-000001
    EDGAR
  • Form C-UNov 22, 20210001860502-21-000004
    EDGAR
  • Form C/ASep 23, 20210001860502-21-000003
    EDGAR
  • Form CJun 24, 20210001860502-21-000002
    EDGAR
Source: ManualCIK 0001860502DEShare price $0.0001

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.